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3D printing technology to control BMP-2 and
VEGF delivery spatially and temporally to promote
large-volume bone regeneration
Ju Young Park,†a Jin-Hyung Shim,†b Song-Ah Choi,a Jinah Jang,a Myungshin Kim,c
Sang Hwa Lee*d and Dong-Woo Cho*e
When large engineered tissue structures are used to achieve tissue regeneration, formation of vasculature
is an essential process. We report a technique that combines 3D printing with spatial and temporal control
of dual growth factors to prevascularize bone tissue. Human dental pulp stem cells (DPSCs) that have
both osteogenic and vasculogenic potential were printed with bone morphogenetic protein-2 (BMP-2) in
the peripheral zone of the 3D printed construct, and with the vascular endothelial growth factor (VEGF) in
the central zone, in which a hypoxic area forms. The structure was implanted in the back of a mouse and
tissue regeneration was assessed after 28 d. Microvessels were newly formed in the hypoxic area of the
printed large volume structure, and angiogenesis from the host tissue was also observed. Bone
regeneration was faster in prevascularized structures than in nonvascularized structures. The 3D-printed
prevascularized structure could be a promising approach to overcome the size limitation of tissue
implants and to enhance bone regeneration.
1. Introduction
Repair of large bone defects is a major challenge in reconstruc-
tive surgery. This surgery entails use of grafts, but the process
has encountered limitations. Autologous bone is the ideal graft
material, because it is the only material with all of osteogenesis,
osteoconduction and osteoinduction potentials.1,2 Use of auto-
logous grafts such as vascular-free flaps improves the clinical
outcome of large bone reconstruction, but this method has
limitations, including significant donor site morbidity, long
operating time, and high cost.3–6 Allografts, xenografts and syn-
thetic grafts have also been used in bone tissue engineering, but
their applicability is limited by lack of osteogenic potential in cells
within the graft material.1,7–10 Several techniques to seed stem
cells into the graft materials have been reported, but in these
methods cell survival in the deep portion of large scaffolds
is compromised due to poor vascularization and consequent
hypoxia and insufficient nutrient delivery.11–13 To achieve rapid
angiogenesis into the graft materials, several studies have used
co-culturemethods (osteogenic and angiogenic cells) and delivery
of dual growth factors (osteogenic and angiogenic factors) to
enhance vascularization into grafted materials.14–17 However,
bone regeneration studies consistently encounter difficulties
when attempting to induce site-specific pharmacological actions
of growth factors and consequent anatomically-appropriate arrange-
ment of cells.
Three-dimensional (3D) printing technology is a manu-
facturing method that uses a layer-by-layer process to build
objects. In the context of tissue engineering, 3D printing tech-
nology can dispense various functional growth factors, and even
live cells with hydrogel, at the desired position until the 3D
tissue is built up. Therefore, 3D printing can produce structures
that have the spatial features of the native tissue.18–20
Mesenchymal dental pulp derived stem cells (DPSCs) from
extracted third molars are promising sources of multipotent
stromal cells in tissue engineering. Accessibility to the extraction
site is easy and those processes present very low morbidity at the
donor site. Use of DPSCs has the additional advantage that the
production yield of cells from the specimen is high.21–24 DPSCs
can differentiate into both osteoblast and odontoblast lineages,25
and have higher osteogenic potential than do mesenchymal stem
cells derived from the bone marrow.26 In particular, DPSCs can
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generate vessel-integrated bone tissue structures, which are
essential for large volume bone reconstruction.21
In the present study, we used 3D printing to fabricate a
scaﬀold laden with DPSCs and spiked with bone morphoge-
netic protein 2 (BMP-2) and vascular endothelial growth factor
(VEGF). The materials used as the scaﬀold were chosen such
that they release BMP-2 slowly and VEGF quickly. BMP-2 was
printed in the periphery zone of the 3D printed construct, and
VEGF was printed in the central zone, in which a hypoxic area
forms. To induce diﬀerentiation of bones and vascular tissue,
DPSCs, which have a high ability to diﬀerentiate into these
tissues, were co-printed with each growth factor in each, and then
the formation of each tissue was evaluated. We hypothesized that
the VEGF printed in the central zone may facilitate early vasculo-
genesis of DPSC and thereby result in suﬃcient blood vessel
formation, whichmight promote bone formation even in the core
of a large structure.
2. Materials and methods
2.1. Regulation of the profiling of the growth factors for bone
and vascular regeneration
To regulate the release profile of each growth factor, 2% (w/v)
collagen type I hydrogel (Koken Co. Ltd, Tokyo, Japan) was used
to obtain sustained release of BMP-2 (5 mg mL1) to induce bone
regeneration, and mixed hydrogel with 10% (w/v) alginate and
10% (w/v) gelatin was used to obtain burst release of VEGF
(2 mg mL1) to induce vascularization. The 3D structure was fabri-
cated by 3D printing technology using themulti-head tissue/organ
building system which was developed in our lab.27 Polycapro-
lactone (PCL; MW 65 000, Sigma-Aldrich, St. Louis, MO, USA)
was melted at 130 1C and dispensed by controlled pneumatic
pressure with a line width of 200 mm and a line height of 100 mm
and a total of twelve PCL lines were printed in parallel with a gap
diameter of 400 mm between PCL lines, to make the frameworks.
Then growth factors encapsulated in each hydrogel were filled
into every second gap between PCL lines (Fig. 1). The dispensed
collagen hydrogel was gelled at 37 1C in 5% CO2 in an incubator
for 30 min. The alginate–gelatin mixture was crosslinked by
incubation with 2% (w/v) CaCl2 solution at 37 1C in 5%CO2 in an
incubator for 15 min. That is, only the alginate part was cross-
linked; to allow burst release of VEGF, the gelatin part was left
without the crosslinking process.
2.1.1. Evaluation of the release profile. To evaluate the release
profile, each structure was incubated in 10 mL of phosphate
buﬀer saline (PBS) buﬀer, and the supernatant was collected every
day for 40 d. The supernatant was analyzed using enzyme-linked
immunosorbent assay (ELISA) to assess the release profiles of
BMP-2 and VEGF from each structure.
2.2. Printing of the structure with DPSCs and growth factors
for in vitro study
DPSCs were isolated as previously described.28 The cell isolation
protocol was approved (approval no. SC11TISE0046) by the Institu-
tional Review Board of the St. Mary’s Hospital the Catholic University
of Korea. DPSCs were cultured in Alpha-modified Eagle’s medium
(a-MEM; Gibco BRL, Grand Island, NY, USA) supplemented with
10% (v/v) fetal bovine serum (FBS; Gibco BRL), 100 UmL1 penicillin
(Gibco BRL), and 0.1 mg mL1 streptomycin (Gibco BRL) (Complete
a-MEMmedia). The culture media were changed every 2 d; 0.05%
trypsin (Gibco BRL) was used to detach the cells from the
culture dish.
DPSCs were encapsulated within 2% collagen type I hydrogel
with BMP-2, and within 10% gelatin/10% alginate mixed hydro-
gel with VEGF (2  106 cells per mL). Then the mixture (cells
and hydrogel solution) was moved to a plastic syringe (10 cc)
equipped with tapered plastic nozzle (200 mm). Pneumatic
pressure (30–50 kPa) was applied to dispense the cell–hydrogel
Fig. 1 Release profile from the 3D structure printed with (A) VEGF using 10% alginate/10% gelatin blended gel (red arrow) and PCL framework (black arrow),
(B) BMP-2 using 2% collagen gel (blue arrow) and PCL framework (black arrow).
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solution mixture. At that time, the printing nozzle was moved at
50–100 mmmin1. The dispensed cell–Col-1 and cell–alginate–
gelatin mixtures were crosslinked as mentioned above. The 3D
structure in which the cells and growth factors were printed was
cultured in complete a-MEM for 14 d to evaluate the viability of
DPSCs after printing and the capacity of the 3D structure to
differentiate into each tissue.
2.2.1. Evaluation of the cell survival rate. First, the survival
rate of printed DPSCs was measured using a live/dead cell assay
kit (Lonza, Walkersville, MD, USA) at 24 h after printing.
Calcein AM and ethidium homodimer (EthD-1) were mixed in
a-MEM medium supplemented with 2% (v/v) FBS and the
mixture was added to cell printed structures, then incubated
at 37 1C in 5% CO2 in an incubator for 15 min. Live and dead
cells were observed under a fluorescence microscope (IX81,
Olympus, Tokyo, Japan), calcein AM (green) indicated live cells
and EthD-1 (red) indicated dead cells.
2.2.2. Analysis of vasculogenic and osteogenic diﬀerentia-
tion. To quantify how the release profiles of the growth factors
aﬀected DPSC diﬀerentiation into bone or vessel, the marker
gene expression of bone and vessel was verified using real-time
PCR (qRT-PCR). Trizol Reagent (Invitrogen, Carlsbad, CA) was
used to isolate total RNA from the structures, and SuperScript II
Reverse Transcriptase (Invitrogen, Carlsbad, CA) was used to
reverse-transcribe the RNA to cDNA. Then, expression of bone and
vascular marker genes was evaluated using amplification primers
(Table 1). The primer for human glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used to standardize the expression
of the other marker genes. qRT-PCR analysis using SYBR Green
(Takara Bio, Kyoto, Japan) was conducted using a Light Cycler 2.0
(Roche, Mannheim, Germany).
2.3. In vivo study
The structures were fabricated with dimensions of 3.8  3.8 
3.8 mm and 5.6  5.6  5.6 mm (width  length  height) to
define the large volume structure (Fig. 4). For fabrication of a
smaller size structure (3.8  3.8  3.8 mm), PCL lines with a
line width of 200 mm and line height of 100 mm were printed
with a pore size of 400 mm; 10 layers of PCL frameworks were
printed with this layer-by-layer process (55 mm3). The larger
size structure (5.6  5.6  5.6 mm) was also fabricated with
this layer-by-layer process but consisted of 15 layers of PCL
frameworks (176 mm3). To map the hypoxic areas in the
structures, DPSCs were seeded onto each structure at a cell
density of 2  103 cells per mm3, and they were incubated in a
static culture for 3 d; then a hypoxia-sensitive staining solution
(Pimonidazole) was applied to the cell culture medium and the
structure was incubated for another 36 h. Then the structure
was fixed in 10% formalin solution and embedded in a freezing
compound (O.C.T. compound, Sakura Finetek Co., Ltd, Tokyo,
Japan). The frozen tissue was sliced into 10 mm-thick sections
using a cryomicrotome (Leica, Wetzler, Germany), and then
Pimonidazole staining was carried out using the Hypoxyprobe-1
Plus Kit (Hypoxyprobe, Inc., Burlington, VT). The tissue slides
were treated with 0.01% Triton X-100 for 5 min at room tem-
perature (RT), then blocked with 1% bovine serum albumin
for 1 h at RT. An FITC-mouse IgG1 monoclonal antibody was
treated with the primary reagent for 16 h at 4 1C. Then the
slides were treated with an anti-FITC antibody for 1 h at RT. The
slides were mounted and observed under a confocal micro-
scope (FV1000, Olympus, Tokyo, Japan).
To verify that vascular printing aﬀected vascularization in the
hypoxic area in vivo, three experimental groups were designed
(Fig. 5): (1) the structure printed with 2% collagen encapsulating
DPSCs, (2) the structure printed with 2% collagen encapsulating
DPSCs and BMP-2, and (3) the structure printed with 10% alginate/
10% gelatin hydrogel encapsulating DPSCs and VEGF in the
hypoxic area of the structure and with 2% collagen encapsulating
DPSCs and BMP-2 in the remaining area except the hypoxic area of
the structure. The fabricated structures were cultured in complete
a-MEM media for 3 d in vitro.
Animal tests were performed with the approval (approval no.
2012-01-0017) of the Institutional Animal Care and Use Com-
mittee of the Pohang University of Science and Technology
(POSTECH), Korea. Ten each of constructs group 1, 2 and 3 were
fabricated, and each was implanted subdermally in the back of
one of the thirty immunodeficient mice (BALB/c-nu/nu, 25 g,
7 weeks old, female) chosen randomly. After 4 weeks, the
structures were harvested and fixed in a 10% formalin solution
for 4 h. After washing with PBS, the structures were embedded
in O.C.T. Compound, and frozen sections of 10 mm thickness
were thaw-mounted on the slides using a cryomicrotome (Leica,
Wetzler, Germany). The frozen sections were labeled with BSI
(Lectin from Bandeiraea simplicifolia; Sigma-Aldrich) to identify
Table 1 PCR primer sequences
Gene Sequence Cycles Melting temperature (1C)
ALP Sense ATGTCATCATGTTCCTGGGAGAT 45 95
Anti-sense TGGAGCTGACCCTTGAGGAT
Runx2 Sense AACCCACGAATGCACTATCCA 45 95
Anti-sense CGGACATACCGAGGGACATG
VE-cadherin Sense CCTGATGCGGCTAGGCATA 45 95
Anti-sense GGAAGAACTGGCCCTTGTCA
PECAM Sense AAATGATCCTGCGGTATTCAAAG 45 95
Anti-sense GCGTGGGAATGGCAATTATC
VEGFR-2 Sense CTCACATGGTACAAGCTTGGC 45 95
Anti-sense TGCCACACGCTCTAGGACTGT
GAPDH Sense CCAGGTGGTCTCCTCTGACTTC 45 95
Anti-sense GTGGTCGTTGAGGGCAATG
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blood endothelial cell diﬀerentiation from the encapsulated
DPSCs in hydrogel with VEGF. Vascular endothelial (VE)-
cadherin, an endothelial specific adhesion molecule, antibody
(Abcam, Cambridge, MA, USA) was also used to verify healthy
blood vessel formation. Nuclei were counterstained with 40,6-
diamidino-2-phenylindole (DAPI). To identify the cell originality
in the host tissue after the structure implantation, tissue sections
were incubated with a human-specific Lamin A/C (NCL-Lam-A/C,
mouse monoclonal IgG2b, 1:200) antibody to detect human cells.
The mounted slides were observed using a confocal microscope
(FV1000, Olympus, Tokyo, Japan). Alizarin Red S staining was
conducted to assess calcium deposition in the structure to verify
the cell diﬀerentiation into calcium-secreted mature bone cells.
Tissue sections were also stained with Masson’s trichrome (MT)
to assess collagen deposition. The stained slides were viewed with
a light microscope (Axiovert 200 M, Carl Zeiss, Oberkochen,
Germany).
2.4. Statistical analysis
All experimental data were expressed as means  standard
deviation from several separate experiments. Statistical analysis
was performed via one-way analysis of variance (ANOVA) with a
post-hoc Tukey test using MINITAB (version 14.2; Minitab, Inc.,
State College, PA). Diﬀerences between experimental groups were
considered statistically significant at p o 0.05.
3. Results
3.1. Regulation of growth factor release rate for bone and
vascular regeneration
According to the ELISA assay; 44% of the total encapsulated
VEGF was released just within 1 d, 67% was released within 5 d
and 69%was released within 10 d (Fig. 1A). In contrast, BMP-2 was
printed using 2% collagen gel to induce a sustained release. In the
release profile, 60% of the encapsulated BMP-2 was released
within 7 d, and 80.5% was consistently released by 40 d (Fig. 1B).
3.2. Evaluation of the cell survival rate
To test the safety of the cell printing process with each hydrogel,
cell viability in each cell-printed structure was evaluated. Cell
viability was calculated by counting the live (green) and dead (red)
cells. One day after printing, the survival rates of the printed cells
with collagen hydrogel and alginate–gelatin mixture were about
92 and 99% respectively (Fig. 2).
3.3. In vitro assessment of the growth factor release rate in
cell diﬀerentiation
VE-Cadherin, PECAM, and VEGFR-2 expression levels in DPSCs
printed using 10% alginate/10% gelatin mixed gel with VEGF
(2 mg mL1) were 27, 42, and 34 times higher, respectively, than
those without VEGF at 7 d after printing (Fig. 3A). ALP and Runx2
expression levels in DPSCs printed using 2% collagen gel with
Fig. 2 Survival rate of DPSCs within the 3D printed structure. (A) Confocal imaging of DPSCs stained with fluorescence dyes for a viability assay. Live
cells were stained with calcein AM (green) and dead cells were stained with ethidium homodimer (red, red arrow). (B) Percentages of live cells. Scale
bar: 100 mm.
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BMP-2 (5 mg mL1) were 2 and 4 times higher at 7 d and 7 and
14 times higher at 14 d after printing, respectively, than those
without BMP-2 (Fig. 3B).
Histological characteristics of vessel and bone were aﬀected
by the treatments. In the structure in which DPSCs were printed
with VEGF using 10% alginate/10% gelatin blended gel, the
BSI-Lectin staining revealed subsequent assembly of encapsu-
lated cells into a vascular network. A filopodia-like structure,
which is the key morphological characteristic of endothelial tip
cells, formed at the edge of the DPSCs just within 1 d, and
interconnections between the cells formed in 3 d. Finally, tube-
like structures, themarker of the functional vessel, were formed in
5 d (Fig. 4A). In contrast, no vascular network formed from DPSCs
in the structure printed using the gel without VEGF (data not
shown). DPSCs printed with BMP-2 using 2% collagen gel were
strongly stained by Alizarin Red S (Fig. 4B), which is specific for
Ca2+ deposition; DPSCs printed using 2% collagen without
BMP-2 were not positively stained by Alizarin Red S (Fig. 4B).
Overall, 2% collagen and 10% alginate/10% gelatin blended gel
were suitable for the sustained and burst release of encapsu-
lated growth factor, respectively, and those structures printed
with VEGF and BMP-2 were eﬀective in inducing vasculogenic
and osteogenic diﬀerentiation, respectively, from DPSCs encap-
sulated in each gel.
3.4. In vivo study
3.4.1. Assessment of the hypoxic areas in the printed
structure. We postulated that a structure greater than a critical
size may need to be prevascularized before it can be used for
large volume tissue regeneration. We fabricated structures of two
sizes, 3.8  3.8  3.8 mm and 5.6  5.6  5.6 mm, to determine
the critical size of structure that can cause a hypoxic volume
within it (Fig. 5A). No-positively-stained cells were observed in
the small structure (3.8 3.8 3.8 mm) (Fig. 5B(a)); on the other
hand, positively-stained (i.e., hypoxic) cells (green fluorescence)
were observed in center of the large (5.6  5.6  5.6 mm)
structure (Fig. 5B(c and i)). Therefore, the structure size of
5.6  5.6  5.6 mm was selected for use in tests to confirm the
regeneration of a large volume of prevascularized bone graft.
3.4.2. In vivo evaluation of 3D printed prevascularized bone
grafts. To verify the eﬀect of spatial and temporal control of
growth factors using 3D printing technology on prevascularized
large bone regeneration, 3D printed structures were designed and
fabricated in three groups (Fig. 6). DPSCs and VEGF encapsulated
in 10% alginate/10% gelatin blended gel were printed in the
hypoxic area confirmed by the Pimonidazole staining, and DPSCs
and BMP-2 encapsulated in 2% collagen gel were printed in the
remaining part of the structure of dimensions 5.6  5.6 
5.6 mm (group 3). Control groups were printed only with DPSCs
or DPSCs and BMP-2 in the whole area of the structures (groups 1
and 2). The structures were implanted in the backs of the mice,
and then harvested 4 weeks later.
Blood vessel formation was observed by BSI-Lectin staining
using the structure harvested at 28 d after implantation.
Vasculature formation in the center was observed only in the
3D-printed prevascularized structure (group 3) (Fig. 7A). On the
other hand, vasculature formation was observed at the bound-
ary area in all groups of the structures (Fig. 7B). The number of
vessels formed in the periphery zone of the structures was
significantly higher in group 3 than in the other groups
(Fig. 7C). These results demonstrate that printed VEGF induced
vasculogenesis from the DPSCs in the hypoxic volume, and
induced angiogenesis from the host tissue within the periphery
zone of the structure.
Bone regeneration was confirmed using MT staining, which
dyes collagen tissue blue, to evaluate the eﬀect of prevascularized
structure on large-volume bone regeneration. Blue-positive
staining, which indicates that the encapsulated cells secreted
Fig. 3 Assessment of the eﬀect of the release profile on vasculogenic and osteogenic diﬀerentiation in vitro. Real-time PCR using (A) (a) DPSC printed
structure using 10% alginate/10% gelatin blend and (b) DPSCs/VEGF printed structure using 10% alginate/10% gelatin blend. (B) (c) DPSC printed scaﬀold
using 2% collagen and (d) DPSCs/BMP-2 printed structure using 2% collagen.
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collagenous proteins, was seldom observed in group 1 and 2,
but group 3 showed strong staining (Fig. 8). However, the degree
of blue-positive staining in the structure of group 3 was
diﬀerent between the outer and center zones. These diﬀerences
demonstrate the importance of oxygen and nutrient delivery for
induction of tissue regeneration, and suggest that 3D printing
technology is useful in inducing formation of blood vessels for
large-volume bone regeneration.
We also quantified expression of vascular and bone marker
genes in DPSCs transplanted with 3D printed structures in vivo
Fig. 4 Histological evaluation of cellular diﬀerentiation. (A) BSI-Lectin staining of the structure printed with DPSCs using 10% alginate/10% gelatin
blended gel with VEGF. (B) Alizarin Red S staining of the structure printed with DPSCs using 2% collagen with or without BMP-2.
Fig. 5 Pimonidazole staining for the confirmation of a hypoxic area formation in the printed structure. (A) Diagram of the printed structures of (a) the
small structure (3.8  3.8  3.8 mm), and (b) the large structure (5.6  5.6  5.6 mm) (B). Observation of positive staining with Pimonidazole (green) and
DAPI (blue) at the center (a, b) and periphery (e, f) zone of the small structure, and the center (c, d) and periphery (g, h) zone of the large structure under
the static culture condition, (i) cross-sectional view of Pimonidazole positive stained area in the large structure.
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(Fig. 9). Vascular marker genes (VE-Cadherin, PECAM, VEGFR-2)
were highly expressed only in the structure of group 3. VE-Cadherin,
PECAM, and VEGFR-2 expression levels in group 3 were 2.7, 8.9,
and 2.7 times higher, respectively, than those in group 2, but the
expression levels did not diﬀer between groups 1 and 2. Bone
marker genes (ALP, Runx2) were highly expressed in the struc-
tures (groups 2 and 3) that had DPSCs printed with BMP-2
using 2% collagen gel. ALP and Runx2 expression levels in
group 2 were 2.7 and 2.0 times higher, respectively, than those
in group 1, and those expression levels in group 3 were 1.34 and
1.25 times higher, respectively, than those in group 2 (Fig. 9B).
These results suggest that temporally and spatially controllable
3D printing technology is eﬀective for inducing large-volume
bone regeneration.
Finally, to determine the eﬀect of the implanted cells
on vascular and bone tissue regeneration, the existence of
implanted human-derived DPSCs in the implanted structures
was confirmed. The structures were labelled using a human
specific Lamin A/C antibody for recognizing human cells;
positively-stained cells were highly expressed in the inner and
periphery zones of the structure of group 3; a much smaller
number of positively-stained cells were observed in the center
and periphery zones of the structures of group 2 and in the
periphery zone of the structure of group 1. Positively-stained
cells were not observed at the center zone in the structure of
group 1 (Fig. 10). These results suggest that printing structure,
especially the prevascularized part, might have a strong influ-
ence on the survival of transplanted DPSCs.
4. Discussion
Artificial vessel formation in a graft is essential to regenerate
both a large volume of tissue and to promote vascular tissue
integration with the host.29 Therefore, many researchers have
tried to fabricate prevascularized artificial grafts. One approach
is to use human mesenchymal stem cells (hMSCs) and endo-
thelial cells derived from the umbilical cord and to combine
them with a fibronectin-containing collagen gel to generate
vascularized bone grafts; the hMSCs present both osteogenic
potential and perivascular feature, and the endothelial cells form
tube-like structures and subsequently networks throughout
the bone scaﬀold.30 Another strategy uses dual growth factors
(BMP-2 and VEGF) to regenerate vascularized bone; BMP-2 is an
eﬀective osteogenic growth factor that is widely used in bone
tissue engineering, and VEGF is a potent vasculogenic factor
that participates in repair of damaged bone.31 Dual delivery of
BMP-2 and VEGF had a synergistic eﬀect on bone formation in
a critical-size rat cranial defect.14 Sequential delivery of VEGF
and BMP-2 can enhance bone regeneration;32,33 in these studies,
the release rate of VEGF was designed to be rapid and that of
BMP-2 was designed to be sustained. However, the usefulness of
Fig. 6 Structure designs. Group 1: DPSCs printed structure using 2% collagen. Group 2: DPSC/BMP-2 printed structure using 2% collagen. Group 3:
DPSC/dual growth factors printed structure using 2% collagen and 10% alginate/10% gelatin blend.
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these methods can be limited when researchers want to
obtain large-volume tissue regeneration because large struc-
tures cannot be built of hydrogel alone and therefore cannot
have suﬃcient mechanical strength to support bone tissue
regeneration.
In the present study, large-volume structures for grafting
into bone defects were fabricated by 3D printing, and stem cells
and dual growth factors were deposited within gel matrices that
were engineered to release the factors in patterns that were
specified temporally and spatially to induce bone regeneration
eﬀectively (Fig. 6). To assess the temporal control of the releas-
ing speed of dual growth factors on tissue regeneration, use the
3D printing system to print two hydrogels: collagen loaded with
recombinant human BMP-2 (rhBMP-2) gelated at 37 1C and an
alginate–gelatin loaded with VEGF prepared by simple blend-
ing, with the crosslinking process using CaCl2 solution for
gelation of only alginate part. Therefore, the non-crosslinked
components were easily diluted by the culture media, thereby
leading to rapid release of VEGF from the gelatin (Fig. 1A),
whereas the release of BMP-2 from the crosslinked 2% collagen
gel was slow (Fig. 1B). The printing of VEGF in only the center of
the structure ensured reduction in the total amount of VEGF
used; this reduction in amount is necessary because excessive
VEGF is strongly correlated to tumour formation.34–36
We also hypothesised that printing VEGF only in the center
would result in the formation of a concentration gradient of the
released VEGF from the center towards the periphery of the
structure, and that this gradient would induce angiogenesis
from the host tissue. By exploiting the temporal and spatial
control, fast neovascularization can be induced from the
printed VEGF and stem cells in the center volume of the large
3D scaﬀold in which hypoxic conditions may occur (Fig. 4); this
vascularization might lead to high viability of printed cells
in the center of the structure, and thereby help to promote
angiogenesis from the host tissue into the implanted artificial
bone graft without formation of an aberrant vasculature (Fig. 7,
group 3).
In addition, observations confirmed that spontaneous
angiogenesis occurred in the periphery portions of the scaﬀold,
but not in the center part as the scaﬀold size increased (Fig. 7A,
group 1). Staining of newly-developed vascular tissue in the
center part showed a tube-like shape, presumed to be internal
movement of red blood cells, thus possibly confirming that blood
was being pumped into the blood vessels. Finally, we confirmed
Fig. 7 Vessel formation in the implanted structures. Observation of positive staining with BSI-Lectin (red), VE-cadherin (green), and DAPI (blue) at the
(A) center and (B) periphery zone of the printed structure of groups 1, 2, and 3. (C) Average number of blood vessels per 0.1 mm2 at three diﬀerent sites in
the implanted structures. Bars: 1 s.d., n = 3; *** p o 0.001.
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enhanced bone tissue regeneration in the prevascularized
structures by assessing deposition of the collagen and marker
gene expression compared to the other groups (Fig. 8). The
promoting eﬀect on bone tissue regeneration would be aﬀected
by the vascularization as well as by the BMP-2. Therefore, this
study demonstrates the importance of oxygen and nutrient
Fig. 8 Masson’s trichrome staining. (A) A cross-sectional view of the structures of group 1 (a), 2 (b), and 3 (c), (red box: central, green box: periphery zone
where the pictures were taken) (B). Observation of center and periphery zone (red and green boxes in (A)) in the structure of group 1, (a, d) group 2 (b, c),
and group 3 (c, f).
Fig. 9 Induction of osteogenic and vasculogenic diﬀerentiation in the 3D printed structures in vivo. Real-time PCR using (A) vasculogenic gene primers and
(B) osteogenic gene primers using the 3D printed structures of group (a) 1, (b) 2, and (c) 3 at 4 weeks after implantation in the backs of mice. Bars: 1 s.d.,
n = 3; *: p o 0.05; **: p o 0.005; ***: p o 0.001.
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delivery for the induction of tissue regeneration, and suggests
that 3D printing technology is a useful technology to construct
structures that can be used to induce formation of blood vessels
for large-volume bone regeneration.
5. Conclusion
We demonstrated that multi-head 3D printing technology
could control the position and release speed of two growth
factors (VEGF, and BMP-2) with dental pulp stem cells (DPSCs)
for vascularized bone tissue engineering. In particular, the
printed VEGF in the hypoxic center of a large scaﬀold induced
fast neovascularization from DPSCs, by which process the hypoxic
condition was alleviated. We believe that the 3D printing technol-
ogy enabling spatial and temporal control of various growth
factors and cells could be extensively applied to heterogeneous
tissue engineering. Future work will focus on pre-clinical evalua-
tion of the 3D-printed structure for regeneration of heterogeneous
tissues in large animals.
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